Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place October 26-28 in New Orleans, Louisiana, USA.
At Booth 1100 in the exhibit hall, Roquette’s Health & Pharma Solutions team will share their expertise across controlled-release technologies, hydroxypropyl beta-cyclodextrins, and sustainable formulation approaches, alongside a comprehensive portfolio of innovative solutions designed to address the evolving needs of pharmaceutical developers.
“AAPS PharmSci 360 is a key opportunity to share our latest innovations, as well as highlight the breadth and depth of our scientific know-how that helps our customers solve complex formulation challenges,” said Peter Freed, Head of Technical Service & Development North America for Roquette’s Health & Pharma Solutions Business Unit. “From advanced drug delivery platforms to sustainability-focused excipient solutions, our team is committed to helping our customers accelerate development, enhance product performance, and bring meaningful therapies to patients.”
Exploring the Science Behind Roquette’s Advanced Solutions
Roquette scientists will present research and technical insights across a range of formulation and drug delivery challenges at AAPS PharmSci 360. Highlights include:
Posters
- To Syringe or Not to Syringe: An Excipient-based Strategy to Reduce Viscosity and Improve Subcutaneous Injectability, lead author Jiayi Huang, Ph.D., Senior Biopharma Scientist, presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist
- Effect of Sodium Alginate Material Attributes on Melatonin Controlled Release Tablet Performance presented by lead author Yeli Zhang, Ph.D., Senior Lead Applications Scientist
- Role of Polyethylene Oxide Molecular Weight and Concentration in Modulating Drug Release from Hydrophilic Matrix Tablets presented by lead author Nasrin Mahmoudi, Ph.D., Senior Lead Applications Scientist
Rapid-fire Talk
- Microbiota-triggered Excipient Unlocks Colon Delivery of Oral mAbs presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist
Technical presentations at the 360 stages in the exhibit hall
- From Molecule to Formulation – How Excipient Properties Impact Product Performance presented by True Rogers, Ph.D., Technical Fellow, and Peter Freed, Ph.D., Head of Technical Service and Development North America.
- Overcoming the Viscosity Barrier: Hydroxypropyl Beta-Cyclodextrin (HPβCD) Enables Ultrafiltration/Diafiltration of High-concentration Protein presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist.
- Enabling Robust GLP-1 Peptide Formulations: Hydroxypropyl-β-Cyclodextrin Enhances Solubility and Stress Stability presented by Wen Chin Foo, Ph.D., Senior Biopharma Scientist.
Learn more about Roquette’s posters, presentations, and booth activities here .
About Roquette
Roquette is a global leader in sustainable plant-based solutions, driving innovation and strong partnerships that are shaping the future of nutrition, health, and bioindustry.
The company harnesses natural resources such as wheat, corn, seaweed, and cellulose to craft high-performance ingredients used in everyday foods, oral medications, advanced biopharmaceuticals, and a range of bio-based products.
A family-owned company with over 90 years of expertise and 11,000 employees, Roquette serves clients in over 150 countries and is committed to creating lasting value for customers, patients, consumers, and society.
Together, we turn the potential of nature into the essentials of life.
Discover more about Roquette here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20261019333675/en/
Contact
Press Contact:
Roquette:
Lisa Luke
Global Head of Communications
Roquette’s Health & Pharma Solutions Business Unit
Email:
lisa.luke@roquette.com
© Business Wire, Inc.
Haftungsausschluss :
Diese Pressemitteilung ist kein von AFP erstelltes Dokument. AFP übernimmt keine Verantwortung für ihren Inhalt. Bei Fragen wenden Sie sich bitte an die im Text der Pressemitteilung genannten Kontaktpersonen/Stellen.